Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands

Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands

US Patent 7576087 · Granted Aug 18, 2009

Estimated economic value: $124,238,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamm2025
Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamm2022
Substituted ethynyl heterobicyclic compounds as tyrosine kinase inhibitors2018
Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands2010
Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-s2010
Amino-5,5-diphenylimidazolone derivatives for the inhibition of β-secretase2010
Oxazolidine derivatives as PR modulators2010
Sulfonyl substituted 1H-indoles as ligands for the 5-hydroxytryptamine receptors2010
Tricyclic oxazolidone derivatives useful as PR modulators2009
Oxazolidone derivatives as PR modulators2009
Sulfonyldihydroimidazopyridinone compounds as 5-hydroxytryptamine-6 ligands2009
1-Heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytrypta2009